Enwei Pharmaceutical 過去の業績
過去 基準チェック /06
Enwei Pharmaceutical's earnings have been declining at an average annual rate of -12%, while the Pharmaceuticals industry saw earnings growing at 9% annually. Revenues have been growing at an average rate of 5.5% per year. Enwei Pharmaceutical's return on equity is 3.5%, and it has net margins of 4.6%.
主要情報
-12.0%
収益成長率
-20.5%
EPS成長率
| Pharmaceuticals 業界の成長 | 10.9% |
| 収益成長率 | 5.5% |
| 株主資本利益率 | 3.5% |
| ネット・マージン | 4.6% |
| 前回の決算情報 | 30 Sep 2024 |
収支内訳
Enwei Pharmaceutical の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。
収益と収入の歴史
| 日付 | 収益 | 収益 | G+A経費 | 研究開発費 |
|---|---|---|---|---|
| 30 Sep 24 | 776 | 35 | 339 | 8 |
| 30 Jun 24 | 778 | 40 | 334 | 12 |
| 31 Mar 24 | 778 | 68 | 306 | 16 |
| 31 Dec 23 | 785 | 86 | 293 | 17 |
| 30 Sep 23 | 778 | 91 | 284 | 18 |
| 30 Jun 23 | 752 | 93 | 268 | 14 |
| 31 Mar 23 | 735 | 75 | 276 | 9 |
| 01 Jan 23 | 692 | 68 | 260 | 8 |
| 30 Sep 22 | 676 | 86 | 253 | 6 |
| 01 Jan 22 | 680 | 102 | 265 | 4 |
| 30 Sep 21 | 675 | 103 | 240 | 4 |
| 31 Dec 20 | 634 | 99 | 243 | 5 |
| 31 Dec 19 | 621 | 83 | 294 | 4 |
| 31 Dec 18 | 593 | 86 | 291 | 4 |
| 31 Dec 17 | 559 | 64 | 272 | 4 |
質の高い収益: 301331 has a large one-off gain of CN¥9.4M impacting its last 12 months of financial results to 30th September, 2024.
利益率の向上: 301331's current net profit margins (4.6%) are lower than last year (11.7%).
フリー・キャッシュフローと収益の比較
過去の収益成長分析
収益動向: 301331's earnings have declined by 12% per year over the past 5 years.
成長の加速: 301331's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
収益対業界: 301331 had negative earnings growth (-61.2%) over the past year, making it difficult to compare to the Pharmaceuticals industry average (-1.2%).
株主資本利益率
高いROE: 301331's Return on Equity (3.5%) is considered low.